Purchase Order 75N93023P01020
Award Date
8/1/23
Potential Completion Date
9/30/23
Potential Value
$15K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Genscript USA Inc. was awarded a $28,860.96 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide research services and supplies in Piscataway, New Jersey. The firm-fixed price contract runs from July 11, 2023 through January 31, 2024 to support NIH/NIAID's efforts to study and address public health issues related to allergies and infectious diseases. No subcontractors or set aside...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $18,152.73 firm fixed price purchase order to Genscript USA Inc. to provide synthesis and purification of DNA plasmid reagents. The place of performance will be Genscript's facility located in Piscataway, New Jersey. Work under this contract is expected to be completed between July 26, 2023 and September 30, 2023. No subcontractors or set aside...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,316.68 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom plasmid preparation services to support biomedical research and public health initiatives. Genscript has extensive experience providing specialized products and services to federal...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for the provision of DNA expression constructs. The contract has a potential value of $12,475.22 and a completion date of November 2, 2023. Genscript has provided similar services to federal agencies in the past, supporting biomedical research and public health initiatives...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $264,030.54 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company, for antibody expression and plasmid preparation services in support of COVID-19 research. The contract, which has a completion date of February 24, 2022, does not have a set-aside designation. Genscript, which has provided similar products and services to...
Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...